Sequestration of vascular endothelial growth factor (VEGF) induces late restrictive lung disease

10Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Rationale: Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases. Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions. Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function. Objectives: To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in long-term modulation of AECII and whole lung function. Methods: Triple transgenic mice expressing the soluble VEGF receptor sFlt-1 specifically in the mesenchyme (Dermo-1/rtTA/sFlt-1) were generated and compared to littermate controls at 3 months to determine the impact of neonatal downregulation of mesenchymal VEGF expression on lung structure, cell composition and function. Reduced tissue VEGF bioavailability has previously been demonstrated with this model. Measurements and Main Results: Triple transgenic mice demonstrated restrictive lung pathology. No differences in gross vascular development or protein levels of vascular endothelial markers was noted, but there was a significant decrease in perivascular smooth muscle and type I collagen. Mutants had decreased expression levels of surfactant protein C and hypoxia inducible factor 1-alpha without a difference in number of type II pneumocytes. Conclusions: These data show that mesenchyme-specific inhibition of VEGF in neonatal mice results in late restrictive disease, making this transgenic mouse a novel model for future investigations on the consequences of neonatal RDS and potential interventions.

References Powered by Scopus

Fiji: An open-source platform for biological-image analysis

43350Citations
N/AReaders
Get full text

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

3564Citations
N/AReaders
Get full text

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

3445Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Poly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid rafts

66Citations
N/AReaders
Get full text

Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins

65Citations
N/AReaders
Get full text

Design, formulation and in vivo evaluation of novel honokiol-loaded PEGylated PLGA nanocapsules for treatment of breast cancer

60Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wieck, M. M., Spurrier, R. G., Levin, D. E., Mojica, S. G., Hiatt, M. J., Reddy, R., … Grikscheit, T. C. (2016). Sequestration of vascular endothelial growth factor (VEGF) induces late restrictive lung disease. PLoS ONE, 11(2). https://doi.org/10.1371/journal.pone.0148323

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

56%

Researcher 7

39%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

40%

Biochemistry, Genetics and Molecular Bi... 8

40%

Agricultural and Biological Sciences 3

15%

Pharmacology, Toxicology and Pharmaceut... 1

5%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free